Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of CAD 250.03 billion. The enterprise value is 313.09 billion.

Market Cap	250.03B
Enterprise Value	313.09B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	81.91%
Float	538.24M

Valuation Ratios

The trailing PE ratio is 23.65 and the forward PE ratio is 15.21.

PE Ratio	23.65
Forward PE	15.21
PS Ratio	4.96
PB Ratio	21.06
P/TBV Ratio	n/a
P/FCF Ratio	22.51
P/OCF Ratio	18.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of 28.19.

EV / Earnings	29.61
EV / Sales	6.26
EV / EBITDA	13.63
EV / EBIT	19.86
EV / FCF	28.19

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.60M
Profits Per Employee	335,641
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 1.73 billion in taxes.

Income Tax	1.73B
Effective Tax Rate	14.09%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	26.51
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.60
Average Volume (20 Days)	9,450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.69

Income Statement

In the last 12 months, Amgen had revenue of CAD 50.39 billion and earned 10.57 billion in profits. Earnings per share was 19.51.

Revenue	50.39B
Gross Profit	35.67B
Operating Income	15.87B
Pretax Income	12.31B
Net Income	10.57B
EBITDA	22.78B
EBIT	15.87B
Earnings Per Share (EPS)	19.51

Balance Sheet

The company has 12.52 billion in cash and 76.01 billion in debt, giving a net cash position of -63.49 billion.

Cash & Cash Equivalents	12.52B
Total Debt	76.01B
Net Cash	-63.49B
Net Cash Per Share	n/a
Equity (Book Value)	11.87B
Book Value Per Share	22.03
Working Capital	4.89B

Cash Flow

In the last 12 months, operating cash flow was 13.65 billion and capital expenditures -2.55 billion, giving a free cash flow of 11.11 billion.

Operating Cash Flow	13.65B
Capital Expenditures	-2.55B
Depreciation & Amortization	6.89B
Net Borrowing	-7.76B
Free Cash Flow	11.11B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 2.82%.

Dividend Per Share	0.72
Dividend Yield	2.82%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	2.63%
Earnings Yield	4.23%
FCF Yield	4.44%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7